The purpose of this study was to recognise predictive biomarkers and explore the promising therapeutic targets of AD with depression. We confirmed a positive correlation between AD and depression through MR Analysis. Through WGCNA analysis, we identified 1569 genes containing two modules, which were most related to AD. In addition, 1629 depressive DEGs were also identified. In these genes, 84 genes were shared by both AD and depression, which were screened by the Degree algorithm, MCC algorithm, and four machine learning algorithms. Two genes (ITGB5 and SPCS1) were confirmed as predictive biomarkers with AUC > 0.7. Furthermore, the nomogram indicated that ITGB5 and SPCS1 are good biomarkers in diagnosing AD with depression. Four drugs targeted at ITGB5 were determined by the DGIdb website. In conclusion, we identified two predictive biomarkers for AD with depression, thus providing promising therapeutic targets for AD with depression.

Download full-text PDF

Source
http://dx.doi.org/10.1111/jcmm.70454DOI Listing

Publication Analysis

Top Keywords

predictive biomarkers
12
promising therapeutic
8
therapeutic targets
8
targets depression
8
itgb5 spcs1
8
depression
7
decoding alzheimer's
4
alzheimer's disease
4
disease depression
4
depression molecular
4

Similar Publications

The purpose of this study was to recognise predictive biomarkers and explore the promising therapeutic targets of AD with depression. We confirmed a positive correlation between AD and depression through MR Analysis. Through WGCNA analysis, we identified 1569 genes containing two modules, which were most related to AD.

View Article and Find Full Text PDF

This review provides an in-depth exploration of the evolving role of immunotherapy in gastrointestinal (GI) cancers, with a particular focus on immune checkpoint inhibitors (ICIs) and their associated predictive biomarkers. We present a detailed analysis of established biomarkers, such as PD-L1, microsatellite instability (MSI), tumor mutational burden (TMB), and the tumor microenvironment (TME), as well as emerging biomarkers, including gut microbiota and Epstein-Barr virus (EBV). The predictive value of these biomarkers in guiding clinical decision-making and optimizing immunotherapy outcomes is thoroughly discussed.

View Article and Find Full Text PDF

CARs for lymphoma.

Best Pract Res Clin Haematol

December 2024

Department of Medicine, Division of Hematology and Hematologic Malignancies, Beth Israel Deaconess Medical Center, Boston, MA, USA.

Chimeric Antigen Receptor (CAR)-T cell therapy has revolutionized treatment options for B-cell Non-Hodgkin Lymphoma (NHL). CD19-targeting CAR-T cell therapy is approved for treatment in Diffuse Large B Cell Lymphoma, Follicular Lymphoma, Mantle Cell Lymphoma, and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma. CAR-T cells demonstrate robust and durable responses even in heavily pretreated patients.

View Article and Find Full Text PDF

Background: Venous thromboembolism (VTE), including pulmonary embolism (PE) and deep vein thrombosis (DVT), is the third most common cardiovascular disease. A low amount of mitochondrial DNA copy number (mtDNA-CN) reflects mitochondrial dysfunctions and has been associations with arterial cardiovascular diseases. However, the role of mtDNA-CN in venous cardiovascular disease was unclear.

View Article and Find Full Text PDF

Cystatin C is associated with osteoporosis and fractures: An observational study based on Mendelian randomization analysis.

Zhong Nan Da Xue Xue Bao Yi Xue Ban

October 2024

Research for Genetic Epidemiology and Genomics, School of Public Health, Suzhou Medical College of Soochow University, Suzhou Jiangsu 215123, China.

Objectives: Osteoporosis is characterized by decreased bone mass and damaged bone microstructure, often leading to fragility fractures. Low bone mineral density is a key risk factor for fractures. Serum cystatin C (CysC), an endogenous marker of glomerular filtration rate, is negatively correlated with bone mineral density and may be a potential risk factor for osteoporosis.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!